Infectious Vaccines Market Forecast to 2028 - COVID-19 Impact and Global Analysis By Size, Share & Trends, Drivers, Restraints, Opportunities, Manufacturer, Applications, And Segments

  • AMR-1064180
  • May 2021
  • Pharmaceuticals
  • 126 Pages
The global Infectious Vaccines market research report provides complete study and detail analysis of the market. This study includes forecast analysis of the market which is based on global and regional level, whereas the research reports the provides forecast data from 2020-2028 and historic of 2018 and 2019. All the values are based on revenue USD Million. Moreover, the market research report describes various segments of the Infectious Vaccines market based on its types, applications and end-use industry. The applications of the market are explained in different industry verticals with reference to major countries across the globe. Along with this, the research report also covers all the major players that are operating in the global Infectious Vaccines market. These major players of the market are further studied and analyzed based on various parameters, such as annual market revenue, annual sales of the company, marketing strategy, historic growth and shipment volumes. Based on all the company’s insights, the market research analyst also suggests business strategy and marketing plans for improving the market position of existing participants of Infectious Vaccines market.
 
Report Parameters Details of Parameter
Market Size xx Million
Based Year 2020
Forecast Period Covered 2020 – 2028
Units for value Revenue in USD million and CAGR from 2020 to 2028
Covered Segments Component, Types, Applications, End-Users, and more.
Companies Covered GlaxoSmithKline plc., Novartis AG, Merck and Co, Inc., Sanofi, Pfizer Inc., Johnson and Johnson, Services Inc., Daiichi Sankyo, Takeda Pharmaceutical Company Limited, CSL Limited, Emergent BioSolutions Inc.
Region Covered North America, Europe, Asia Pacific, Latin America, Middle East and Africa

COVID-19 Impact Analysis
The analysis of covid-19 is based on the impact of the current pandemic situation on market scenarios. This includes impact of covid-19 outbreak on overall revenue, market segments as well as regional market. The report also puts light on detailed impact analysis by taking into consideration all the government policies imposed during the pandemic situation, temporary shutdown of manufacturing units, current state of supply chain and distributors, and its future impacts on the growth of overall market. The market study will assist user to understand the global demand and impose strategic business plans to compete with the peers.

Apart from this, the market research report also covers drivers and restraints for the global Infectious Vaccines market and their impact on the demand and supply during the forecast period. Along with this, the research report also provides Infectious Vaccines market trends and opportunities that are based on regional and global level. Furthermore, the market research report also provides the major distributors and manufacturers that are operating in all the key region across the world. The researched data provided in the report is widely used by various industry players to strengthen their distribution channel and improve the geographical reach. In addition, the report also covers all the major players of the global Infectious Vaccines market and its key offerings and solutions. The report also provides recent mergers and acquisitions of these key players.

The data which is provided in the market research report is analyzed and evaluated with the help of various marketing tools, such as SWOT analysis, Poster’s Five Force analysis, PESTEL analysis, value chain analysis, player positioning analysis and market share analysis. Therefore, this analysis tools helps the analyst to evaluate the Infectious Vaccines market based on various parameters such as capital investments, impact of consumer’s preferences, economies of scale, manufacturing rights and patents, existing distribution channels, switching costs, government regulations and brand loyalty.

Major Key Players for Global Infectious Vaccines Market:
The Infectious Vaccines market research report offers the company profile of major key players including progress trends, competitive landscape breakdown, and key in regions development status. GlaxoSmithKline plc., Novartis AG, Merck and Co, Inc., Sanofi, Pfizer Inc., Johnson and Johnson, Services Inc., Daiichi Sankyo, Takeda Pharmaceutical Company Limited, CSL Limited, Emergent BioSolutions Inc.

Infectious Vaccines Market Segment Analysis:
By Type
Inactivated Vaccines
Live Attenuated Vaccines
DNA and Recombinant Vector Vaccines
Others
Disease
Typhoid
Tuberculosis
Tetanus and Diphtheria
Influenza
Hepatitis
Polio
Others
Distribution Channel
Hospitals and Retail Pharmacies
Online Distribution


Geographic Coverage for Infectious Vaccines Market:
The market research report on global Infectious Vaccines market offers complete analysis across various regions across the world. The Infectious Vaccines market is distributed into various regions such as North America, Europe, Asia Pacific, Latin America and Middle East and Africa. The global leading market share as per the region is evaluated after considering Infectious Vaccines market revenue, sales, shares, recent developments, innovations and growth rates. This section of regional analysis provides widespread evaluation of the industry from various countries and regions.

North America Infectious Vaccines Market Value and Forecast
  • US
  • Canada
Europe Infectious Vaccines Market Value and Forecast
  • UK
  • Germany
  • France
  •  Rest of Europe
Asia Pacific Infectious Vaccines Market Value and Forecast
  • China
  • Japan
  • India
  • Rest of Asia Pacific
Latin America Infectious Vaccines Market Value and Forecast
  • Mexico
  • Brazil
  • Rest of Latin America
Middle East and Africa Infectious Vaccines Market Value and Forecast
  • GCC Countries
  • South Africa
  • Rest of Middle East and Africa


Key highlights of the Infectious Vaccines market report:
  • The report provides key trends of the global Infectious Vaccines market
  • The report also covers consumer preferences and current industry growth
  • Key products or solutions offered by the main players in the Infectious Vaccines industry
  • The report covers all the recent developments of the Infectious Vaccines market and helps to provide current industry updates
  • The report covers a detailed look over the global Infectious Vaccines Industry and provides with significant actionable insights
  • The Infectious Vaccines market estimation from 2020-2028 and historical data for 2018 and 2019
  • The market study also provides data on changing market dynamics, market intelligence, current and future market trends
  • The report also analyses the microeconomic and macroeconomic factors that are affecting the global Infectious Vaccines market
  • In-depth analysis of the market’s competitive landscape and detailed information about the vendors
  • The report also offers key market drivers, restrains, trends and opportunities with present and future impact on the market
  • Detailed information about the major players or manufacturers of the global Infectious Vaccines market
  • Comprehensive analysis of the Infectious Vaccines market segments based on its types, applications and end-use industry
Key Analytical Areas:
The report aims to offer a complete solution to various businesses operating in the Infectious Vaccines market in making strategic decisions based on credible information and actionable insights. Thereby, the report covers various aspects of your requirements such as industry overview, market dynamics, regional analysis and competitive landscape. The report aims to provide insights to businesses in the Infectious Vaccines market for numerous purposes such as:

     1. Strategic Decision Making:
With the help of this report, key decision makers can quickly analyze and identify growth opportunities in terms of numerous segments across various geographical regions. Thereby, this report enables organizations to identify and make strategic investments in specific market segments in order to gain maximum return on investment.

      2.  Actionable Insights:
The report offers a deep dive into how companies are leveraging market conditions to make the most in the Infectious Vaccines market. Thereby, the report offers numerous actionable insights into the best practices and key success factors relevant in the Infectious Vaccines market. Using the insights included in the report, businesses can make quick decisions to achieve success in business operations.

      3. Competitive Snapshot:
In addition, to detailed information on the companies operating in the Infectious Vaccines market, the report also includes a competitive snapshot of all the companies covered in the report. Thereby, this offers a visual representation of how all the companies stand comparatively based on their competencies, geographic presence, market hold, years of operations, employee and financial strength, among others.

Manufacturers and Segments

  • GlaxoSmithKline plc.
  • Novartis AG
  • Merck and Co, Inc.
  • Sanofi
  • Pfizer Inc.
  • Johnson and Johnson, Services Inc.
  • Daiichi Sankyo
  • Takeda Pharmaceutical Company Limited
  • CSL Limited
  • Emergent BioSolutions Inc.
  • Inactivated Vaccines
  • Live Attenuated Vaccines
  • DNA and Recombinant Vector Vaccines
  • Others
  • Hospitals and Retail Pharmacies
  • Online Distribution

Have query on this report?

Make an Enquiry
1. Preface
     1.1. Report Scope and Description
     1.2. Research Methodology
          1.2.1. Phase I-Secondary Research
          1.2.2. Phase II-Primary Research
          1.2.3. Phase II-Expert Panel Review
          1.2.4. Assumptions
          1.2.5. Approach Adopted

2. Executive Summarysegment Form
     2.1. Global Infectious Vaccines Market Snapshot
          2.1.1. Global Infectious Vaccines Market By Type,2019
               2.1.1.1.Inactivated Vaccines
               2.1.1.2.Live Attenuated Vaccines
               2.1.1.3.DNA and Recombinant Vector Vaccines
               2.1.1.4.Others
          2.1.2. Global Infectious Vaccines Market By Distribution Channel,2019
               2.1.2.1.Hospitals and Retail Pharmacies
               2.1.2.2.Online Distribution
          2.1.3. Global Infectious Vaccines Market By End-use,2019
          2.1.4. Global Infectious Vaccines Market By Geography,2019

3. Global Infectious Vaccines Market Dynamics
     3.1. Market Overview
     3.2. Market Inclination Insights Analysis
     3.3. Drivers
     3.4. Challenges
     3.5. Future Prospects
     3.6. Impact Analysis of Drivers and Challenges During the Forecast Period, (2020-2028)

4. Global Infectious Vaccines Market Size (US$), By Type, 2018 – 2028 
     4.1. Overview
          4.1.1. Market Share Analysis By Type, 2019 vs.2028
          4.1.2. Attractive Investment Proposition By Type, 2020
     4.2. Global Infectious Vaccines Market Size (US$), By Type, 2018 – 2028

5. Global Infectious Vaccines Market Size (US$), By Distribution Channel, 2018 – 2028 
     5.1. Overview
          5.1.1. Market Share Analysis By Distribution Channel, 2019 vs.2028
          5.1.2. Attractive Investment Proposition By Distribution Channel, 2020
     5.2. Global Infectious Vaccines Market Size (US$), By Distribution Channel, 2018 – 2028

6. Global Infectious Vaccines Market Size (US$), By End-use, 2018 – 2028 
     6.1. Overview
          6.1.1. Market Share Analysis By End-use, 2019 vs.2028
          6.1.2. Attractive Investment Proposition By End-use, 2020
     6.2. Global Infectious Vaccines Market Size (US$), By End-use, 2018 – 2028

7. Global Infectious Vaccines Market Size (US$), By Geography, 2018 – 2028
     7.1. Overview
          7.1.1. Market Share Analysis by Geography, 2019 vs. 2028
          7.1.2. Attractive Investment Proposition by Geography, 2020
     7.2. North America Infectious Vaccines Market Analysis, 2018 – 2028 
          7.2.1. North America Infectious Vaccines Market Size (US$), By Country, 2018 – 2028 
               7.2.1.1. U.S.
               7.2.1.2. Canada
          7.2.2. North America Infectious Vaccines Market Size (US$), By Type, 2018 – 2028
          7.2.3. North America Infectious Vaccines Market Size (US$), By Distribution Channel, 2018 – 2028
          7.2.4. North America Infectious Vaccines Market Size (US$), By End-use, 2018 – 2028
     7.3. Europe Infectious Vaccines Market Analysis, 2018 – 2028 
          7.3.1.  Europe Infectious Vaccines Market Size (US$), By Country, 2018 – 2028 
               7.3.1.1. U.K.
               7.3.1.2. Germany
               7.3.1.3. France
               7.3.1.4. Rest of Europe
          7.3.2. Europe Infectious Vaccines Market Size (US$), By Type, 2018 – 2028
          7.3.3. Europe Infectious Vaccines Market Size (US$), By Distribution Channel, 2018 – 2028
          7.3.4. Europe Infectious Vaccines Market Size (US$), By End-use, 2018 – 2028
     7.4. Asia Pacific Infectious Vaccines Market Analysis , 2018 – 2028
          7.4.1.  Asia Pacific Infectious Vaccines Market Size (US$), By Country, 2018 – 2028 
               7.4.1.1. China
               7.4.1.2. Japan
               7.4.1.3. India
               7.4.1.4. Rest of Asia Pacific
          7.4.2. Asia Pacific Infectious Vaccines Market Size (US$), By Type, 2018 – 2028
          7.4.3. Asia Pacific Infectious Vaccines Market Size (US$), By Distribution Channel, 2018 – 2028
          7.4.4. Asia Pacific Infectious Vaccines Market Size (US$), By End-use, 2018 – 2028
     7.5. Latin America Infectious Vaccines Market Analysis, 2018 – 2028 
          7.5.1.  Latin America Infectious Vaccines Market Size (US$), By Country, 2018 – 2028 
               7.5.1.1. Brazil
               7.5.1.2. Mexico
               7.5.1.3. Rest of Latin America
          7.5.2. Latin America Infectious Vaccines Market Size (US$), By Type, 2018 – 2028
          7.5.3. Latin America Infectious Vaccines Market Size (US$), By Distribution Channel, 2018 – 2028
          7.5.4. Latin America Infectious Vaccines Market Size (US$), By End-use, 2018 – 2028
     7.6. Middle East & Africa (MEA) Infectious Vaccines Market Analysis, 2018 – 2028 
          7.6.1.  MEA Infectious Vaccines Market Size (US$), By Region, 2018 – 2028 
               7.6.1.1. GCC Countries
               7.6.1.2. South Africa
               7.6.1.3. Rest of MEA
          7.6.2. MEA Infectious Vaccines Market Size (US$), By Type, 2018 – 2028
          7.6.3. MEA Infectious Vaccines Market Size (US$), By Distribution Channel, 2018 – 2028
          7.6.4. MEA Infectious Vaccines Market Size (US$), By End-use, 2018 – 2028

8. Company Profiles
     8.1. Competitive Analysis 
     8.2. Market Positioning of Key Vendors 
     8.3. Key Strategies adopted by the Leading Players
     8.4. Key Infectious Vaccines Providers
        8.4.1 GlaxoSmithKline plc.
                8.4.1.1 Business Description
                8.4.1.2 GlaxoSmithKline plc. Geographic Operations
                8.4.1.3 GlaxoSmithKline plc. Financial Information
                8.4.1.4 GlaxoSmithKline plc. Product Positions/Portfolio
                8.4.1.5 GlaxoSmithKline plc. Key Developments
        8.4.2 Novartis AG
                8.4.2.1 Business Description
                8.4.2.2 Novartis AG Geographic Operations
                8.4.2.3 Novartis AG Financial Information
                8.4.2.4 Novartis AG Product Positions/Portfolio
                8.4.2.5 Novartis AG Key Developments
        8.4.3 Merck and Co, Inc.
                8.4.3.1 Business Description
                8.4.3.2 Merck and Co, Inc. Geographic Operations
                8.4.3.3 Merck and Co, Inc. Financial Information
                8.4.3.4 Merck and Co, Inc. Product Positions/Portfolio
                8.4.3.5 Merck and Co, Inc. Key Developments
        8.4.4 Sanofi
                8.4.4.1 Business Description
                8.4.4.2 Sanofi Geographic Operations
                8.4.4.3 Sanofi Financial Information
                8.4.4.4 Sanofi Product Positions/Portfolio
                8.4.4.5 Sanofi Key Developments
        8.4.5 Pfizer Inc.
                8.4.5.1 Business Description
                8.4.5.2 Pfizer Inc. Geographic Operations
                8.4.5.3 Pfizer Inc. Financial Information
                8.4.5.4 Pfizer Inc. Product Positions/Portfolio
                8.4.5.5 Pfizer Inc. Key Developments
        8.4.6 Johnson and Johnson, Services Inc.
                8.4.6.1 Business Description
                8.4.6.2 Johnson and Johnson, Services Inc. Geographic Operations
                8.4.6.3 Johnson and Johnson, Services Inc. Financial Information
                8.4.6.4 Johnson and Johnson, Services Inc. Product Positions/Portfolio
                8.4.6.5 Johnson and Johnson, Services Inc. Key Developments
        8.4.7 Daiichi Sankyo
                8.4.7.1 Business Description
                8.4.7.2 Daiichi Sankyo Geographic Operations
                8.4.7.3 Daiichi Sankyo Financial Information
                8.4.7.4 Daiichi Sankyo Product Positions/Portfolio
                8.4.7.5 Daiichi Sankyo Key Developments
        8.4.8 Takeda Pharmaceutical Company Limited
                8.4.8.1 Business Description
                8.4.8.2 Takeda Pharmaceutical Company Limited Geographic Operations
                8.4.8.3 Takeda Pharmaceutical Company Limited Financial Information
                8.4.8.4 Takeda Pharmaceutical Company Limited Product Positions/Portfolio
                8.4.8.5 Takeda Pharmaceutical Company Limited Key Developments
        8.4.9 CSL Limited
                8.4.9.1 Business Description
                8.4.9.2 CSL Limited Geographic Operations
                8.4.9.3 CSL Limited Financial Information
                8.4.9.4 CSL Limited Product Positions/Portfolio
                8.4.9.5 CSL Limited Key Developments
        8.4.10 Emergent BioSolutions Inc.
                8.4.10.1 Business Description
                8.4.10.2 Emergent BioSolutions Inc. Geographic Operations
                8.4.10.3 Emergent BioSolutions Inc. Financial Information
                8.4.10.4 Emergent BioSolutions Inc. Product Positions/Portfolio
                8.4.10.5 Emergent BioSolutions Inc. Key Developments

LIST OF TABLES

TABLE 1 Market Snapshot: Global Infectious Vaccines Market 
TABLE 2 Impact Indicators 
TABLE 3 Impact Analysis of Drivers and Restraints 
TABLE 4 North America Infectious Vaccines Market Revenue, By Type, 2018 – 2028 (US$ Mn) 
TABLE 5 North America Infectious Vaccines Market Revenue, By Distribution Channel, 2018 – 2028 (US$ Mn) 
TABLE 6 North America Infectious Vaccines Market Revenue, By End-use, 2018 – 2028 (US$ Mn) 
TABLE 7 Europe Infectious Vaccines Market Revenue, By Type, 2018 – 2028 (US$ Mn) 
TABLE 8 Europe Infectious Vaccines Market Revenue, By Distribution Channel, 2018 – 2028 (US$ Mn) 
TABLE 9 Europe Infectious Vaccines Market Revenue, By End-use, 2018 – 2028 (US$ Mn) 
TABLE 10 Asia Pacific Infectious Vaccines Market Revenue, By Type, 2018 – 2028 (US$ Mn) 
TABLE 11 Asia Pacific Infectious Vaccines Market Revenue, By Distribution Channel, 2018 – 2028 (US$ Mn) 
TABLE 12 Asia Pacific Infectious Vaccines Market Revenue, By End-use, 2018 – 2028 (US$ Mn) 
TABLE 13 Latin America Infectious Vaccines Market Revenue, By Type, 2018 – 2028 (US$ Mn) 
TABLE 14 Latin America Infectious Vaccines Market Revenue, By Distribution Channel, 2018 – 2028 (US$ Mn) 
TABLE 15 Latin America Infectious Vaccines Market Revenue, By End-use, 2018 – 2028 (US$ Mn)
TABLE 16 MEA Infectious Vaccines Market Revenue, By Type, 2018 – 2028 (US$ Mn) 
TABLE 17 MEA Infectious Vaccines Market Revenue, By Distribution Channel, 2018 – 2028 (US$ Mn) 
TABLE 18 MEA Infectious Vaccines Market Revenue, By End-use, 2018 – 2028 (US$ Mn)

LIST OF FIGURES

FIG. 1 Global Infectious Vaccines: Market Segmentation 
FIG. 2 Global Infectious Vaccines Market: Research Methodology 
FIG. 3 Top-Down and Bottom-up Approach 
FIG. 4 Global Infectious Vaccines Market, By Type, 2019 (US$ Mn) 
FIG. 5 Global Infectious Vaccines Market, By Distribution Channel, 2019 (US$ Mn) 
FIG. 6 Global Infectious Vaccines Market, By End-use, 2019 (US$ Mn) 
FIG. 7 Global Infectious Vaccines Market, By Geography, 2019 (US$ Mn) 
FIG. 8 Global Infectious Vaccines Market Revenue and Growth, 2018 – 2028, (US$ Mn) (Y-o-Y %)
FIG. 9 Attractive Investment Proposition 
FIG. 10 Market Positioning of Key Infectious Vaccines Providers, 2019
FIG. 11 Global Infectious Vaccines Market Revenue Contribution, By Type, 2019 & 2028 (Value %) 
FIG. 12 Global Infectious Vaccines Market Revenue Contribution, By Distribution Channel, 2019 & 2028 (Value %) 
FIG. 13 Global Infectious Vaccines Market Revenue Contribution, By End-use, 2019 & 2028 (Value %) 
FIG. 14 North America Infectious Vaccines Market Revenue, 2018 – 2028, (US$ Mn) 
FIG. 15 Europe Infectious Vaccines Market Revenue, 2018 – 2028, (US$ Mn) 
FIG. 16 Asia Pacific Infectious Vaccines Market Revenue, 2018 – 2028, (US$ Mn) 
FIG. 17 Latin America Infectious Vaccines Market Revenue, 2018 – 2028, (US$ Mn)
FIG. 18 MEA Infectious Vaccines Market Revenue, 2018 – 2028, (US$ Mn)

Key Takeaways:

1. Market value and estimate of the Infectious Vaccines market for the period from 2020 to 2028
2. Compounded annual growth rate (CAGR%) for individual segments in various regional markets for a period from 2020 to 2028
3. Value chain analysis
4. Market share study combined with competitive landscape of major players
5. Profiles of major market players covering overall business operations, geographic occurrence, product portfolio, financial status and news coverage 

List of Tables

TABLE  Market Snapshot: Global Infectious Vaccines Market
TABLE  Impact Pointers
TABLE  Impact Analysis of Drivers and Restraints
TABLE  North America Infectious Vaccines Market Value, By Segment1, 2018 – 2028
TABLE  North America Infectious Vaccines Market Value, By Segment2, 2018 – 2028
TABLE  North America Infectious Vaccines Market Value, By Country, 2018 – 2028
TABLE  Europe Infectious Vaccines Market Value, By Segment1, 2018 – 2028
TABLE  Europe Infectious Vaccines Market Value, By Segment2, 2018 – 2028
TABLE  Europe Infectious Vaccines Market Value, By Country, 2018 – 2028
TABLE  Asia Pacific Infectious Vaccines Market Value, By Segment1, 2018 – 2028
TABLE  Asia Pacific Infectious Vaccines Market Value, By Segment2, 2018 – 2028
TABLE  Asia Pacific Infectious Vaccines Market Value, By Country, 2018 – 2028
TABLE  Latin America Infectious Vaccines Market Value, By Segment1, 2018 – 2028
TABLE  Latin America Infectious Vaccines Market Value, By Segment2, 2018 – 2028
TABLE  Latin America Infectious Vaccines Market Value, By Country, 2018 – 2028
TABLE  MEA Infectious Vaccines Market Value, By Segment1, 2018 – 2028
TABLE  MEA Infectious Vaccines Market Value, By Segment2, 2018 – 2028
TABLE  MEA Infectious Vaccines Market Value, By Country, 2018 – 2028
TABLE  GlaxoSmithKline plc.: Company Snapshot (Company Details, Geographical Presence, Product Portfolio, Recent News and Announcements)
TABLE  Novartis AG: Company Snapshot (Company Details, Geographical Presence, Product Portfolio, Recent News and Announcements)
TABLE  Merck and Co, Inc.: Company Snapshot (Company Details, Geographical Presence, Product Portfolio, Recent News and Announcements)
TABLE  Sanofi: Company Snapshot (Company Details, Geographical Presence, Product Portfolio, Recent News and Announcements)
TABLE  Pfizer Inc.: Company Snapshot (Company Details, Geographical Presence, Product Portfolio, Recent News and Announcements)
TABLE  Johnson and Johnson, Services Inc.: Company Snapshot (Company Details, Geographical Presence, Product Portfolio, Recent News and Announcements)
TABLE  Daiichi Sankyo: Company Snapshot (Company Details, Geographical Presence, Product Portfolio, Recent News and Announcements)
TABLE  Takeda Pharmaceutical Company Limited: Company Snapshot (Company Details, Geographical Presence, Product Portfolio, Recent News and Announcements)
TABLE  CSL Limited: Company Snapshot (Company Details, Geographical Presence, Product Portfolio, Recent News and Announcements)
TABLE  Emergent BioSolutions Inc.: Company Snapshot (Company Details, Geographical Presence, Product Portfolio, Recent News and Announcements)
 

List of Figures

FIG.  Global Infectious Vaccines Market: Research Methodology
FIG.  Top-Down and Bottom Up Approach
FIG.  Global Infectious Vaccines Market, By Segment1, 2019 (US$ Mn)
FIG.  Global Infectious Vaccines Market, By Segment2, 2019 (US$ Mn)
FIG.  Global Infectious Vaccines Market, By Geography, 2019 (US$ Mn)
FIG.  Global Infectious Vaccines Market Value and Growth, 2018 – 2028, (US$ Mn) (Y-o-Y %)
FIG.  Attractive Investment Proposition
FIG.  Market Positioning of Key Infectious Vaccines Providers, 2016
FIG.  Global Infectious Vaccines Market Value Share, By Segment1, 2019 & 2028 (% Value)
FIG.  Global Live Attenuated Vaccines Market Value, 2018 – 2028, (US$ Mn)
FIG.  Global DNA and Recombinant Vector Vaccines Market Value, 2018 – 2028, (US$ Mn)
FIG.  Global Others Market Value, 2018 – 2028, (US$ Mn)
FIG.  Global Market Value, 2018 – 2028, (US$ Mn)
FIG.  Global Infectious Vaccines Market Value Share, By Segment2, 2019 & 2028 (% Value)
FIG.  Global Online Distribution Market Value, 2018 – 2028, (US$ Mn)
FIG.  Global Market Value, 2018 – 2028, (US$ Mn)
FIG.  U.S. Infectious Vaccines Market Value, 2018 – 2028, (US$ Mn)
FIG.  Canada Infectious Vaccines Market Value, 2018 – 2028, (US$ Mn)
FIG.  UK Infectious Vaccines Market Value, 2018 – 2028, (US$ Mn)
FIG.  Germany Infectious Vaccines Market Value, 2018 – 2028, (US$ Mn)
FIG.  France Infectious Vaccines Market Value, 2018 – 2028, (US$ Mn)
FIG.  Rest of Europe Infectious Vaccines Market Value, 2018 – 2028, (US$ Mn)
FIG.  China Infectious Vaccines Market Value, 2018 – 2028, (US$ Mn)
FIG.  Japan Infectious Vaccines Market Value, 2018 – 2028, (US$ Mn)
FIG.  India Infectious Vaccines Market Value, 2018 – 2028, (US$ Mn)
FIG.  Rest of Asia Pacific Infectious Vaccines Market Value, 2018 – 2028, (US$ Mn)
FIG.  Mexico Infectious Vaccines Market Value, 2018 – 2028, (US$ Mn)
FIG.  Brazil Infectious Vaccines Market Value, 2018 – 2028, (US$ Mn)
FIG.  Rest of Latin America Infectious Vaccines Market Value, 2018 – 2028, (US$ Mn)
FIG.  GCC Countries Infectious Vaccines Market Value, 2018 – 2028, (US$ Mn)
FIG.  South Africa Infectious Vaccines Market Value, 2018 – 2028, (US$ Mn)
FIG.  Rest of MEA Infectious Vaccines Market Value, 2018 – 2028, (US$ Mn)